Cancer Immunotherapy Side Effects May Be Reversible: Scientists Find Stabilizing Regulatory T Cells Can Curb Immune-Related Inflammation
Immune checkpoint inhibitors can unleash the immune system against healthy tissue, causing immune-related adverse events in 20%–40% of patients. New research identifies regulatory T cell fragility as a key driver and shows that blocking a specific protein, improving diet, or supplementing metabolites can stabilize these cells and reverse inflammation in mice.